Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer (Q33778439)

29 July 2017

title

Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer (English)

1 reference

29 July 2017

Deniz Abat

1

1 reference

29 July 2017

Osman Demirhan

2

1 reference

29 July 2017

Nihal Inandiklioglu

3

1 reference

29 July 2017

Erdal Tunc

4

1 reference

29 July 2017

Seyda Erdogan

5

1 reference

29 July 2017

Deniz Tastemir

6

1 reference

29 July 2017

Inayet Nur Uslu

7

1 reference

29 July 2017

Zuhtu Tansug

8

1 reference

29 July 2017

language of work or name

1 reference

2 May 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

8

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

25-32

1 reference

29 July 2017

cites work

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Urine cytology and adjunct markers for detection and surveillance of bladder cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Biomarkers in bladder cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Bladder cancer in 2010: how far have we come?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Molecular markers for detection, surveillance and prognostication of bladder cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Methylation-associated silencing of TU3A in human cancers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

The genetics of bladder cancer: a cytogeneticist's perspective

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

The tumor suppressor RASSF1A in human carcinogenesis: an update

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

The genetics of transitional cell carcinoma: progress and potential clinical application

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Fluorescence in situ hybridization with DNA probes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Prognostic value of p53 for high risk superficial bladder cancer with long-term followup

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Genetic instability in superficial bladder cancer and adjacent mucosa: an interphase cytogenetic study.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Coincidence in fragile site expression with fluorodeoxyuridine and bromodeoxyuridine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063627

Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24959214

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24959214

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24959214

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3892/OL.2014.2108

1 reference

29 July 2017

1 reference

29 July 2017

1 reference